Swiss pharma firm Sandoz takes note of proposed US tariffs on generic drugs

Generic drugs giant Sandoz said on Wednesday that it had “taken note” of Washington’s announcements regarding new tariffs on this type of medication, adding that it was “still too early” to assess the implications. "At this stage, it is too early to assess the potential implications, as further details on the implementation and scope of this measure are still required", particularly regarding the group’s geographical presence and its "future investment decisions", said a spokesperson for the…